Aquila Investment Management LLC Biomarin Pharmaceutical Inc Transaction History
Aquila Investment Management LLC
- $96.9 Million
- Q2 2024
A detailed history of Aquila Investment Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Aquila Investment Management LLC holds 13,000 shares of BMRN stock, worth $1.09 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
13,000
Previous 13,000
-0.0%
Holding current value
$1.09 Million
Previous $1.14 Million
5.73%
% of portfolio
1.1%
Previous 1.03%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
631Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.91 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.6 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.58 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.17 Billion0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$815 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...